Literature DB >> 17330543

Fatal spontaneous thrombosis of a cerebral arteriovenous malformation in a young patient with a rare heterozygous prothrombin gene mutation. Case report.

Mahmoud Taha1, Umang Patel, Stephen B Wharton, Peter C Cooper, Michael Makris.   

Abstract

The authors report a case of fatal stroke due to thrombosis of a cerebral arteriovenous malformation (AVM) in a young patient. The patient presented with a progressive severe headache that had lasted for a few days, followed by a rapid deterioration in the level of consciousness. Computed tomography and magnetic resonance imaging were immediately performed, and the images showed a large area of venous ischemia in the left hemisphere as well as a left temporal pial AVM. An emergency decompressive craniectomy was unsuccessful in preventing deterioration in the patient's condition. An autopsy examination revealed a thrombosed AVM leading to a wide area of venous ischemia and massive brain swelling. Thrombophilia investigations identified a heterozygous mutation at position 20209 of the prothrombin gene, a recently reported rare prothrombotic defect. Acute neurological decline after spontaneous thrombosis of an intracranial AVM is rare, and an association with the prothrombin defect in this patient is likely.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330543     DOI: 10.3171/ped.2007.106.2.143

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  2 in total

1.  Delayed ischemic stroke following spontaneous thrombosis of an arteriovenous malformation.

Authors:  Ashish Harish Shah; Diogo C Haussen; Brian M Snelling; Roberto C Heros; Dileep R Yavagal
Journal:  BMJ Case Rep       Date:  2013-09-18

2.  A deep vein thrombosis caused by 20209C>T mutation in homozygosis of the prothrombin gene in a Caucasian patient.

Authors:  Silvia Izquierdo Alvarez; Eva Barrio Ollero; Francisco Miguel Llinares Sanjuan; Fabiola Lorente Martínez; María Teresa Calvo Martín
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.